期刊文献+
共找到1篇文章
< 1 >
每页显示 20 50 100
Anti-vascular endothelial growth factor: the future treatment of choroidal neovascularization in pathologic myopia 被引量:3
1
作者 ZHU Hong WANG Feng-hua SUN Xiao-dong 《Chinese Medical Journal》 SCIE CAS CSCD 2013年第8期1578-1583,共6页
-yopia is the most common refractive disorder. High .myopia affects 27%-33% of all myopic eyes inAsia.1,2 ;The pathologic myopia (PM) is the most severe vision-threatening phenotype of high myopia.3 It is also the s... -yopia is the most common refractive disorder. High .myopia affects 27%-33% of all myopic eyes inAsia.1,2 ;The pathologic myopia (PM) is the most severe vision-threatening phenotype of high myopia.3 It is also the second most common cause of choroidal neovascularization (CNV) in Asia. Unlike age-related macular degeneration (AMD) which mostly effecting elders, PM causes severe vision loss in young adults, resulting in a significant impairment of their working ability.4 PM has become the second leading cause of low vision and blindness particularly among those aged at 40-49 years in some Asia countries. 展开更多
关键词 choroidal neovascular anti-vascular endothelial growth factor treatment pathologic myopia
原文传递
上一页 1 下一页 到第
使用帮助 返回顶部